Journal article · 2025 · Open access

Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis

Jeong Min Yu, John M. VanBuren, Angela Child, Jessica S. Alvey, Lisa A. Mandl, Laura C. Pinheiro, Shervin Assassi, Elana J. Bernstein, Flavia V. Castelino, Lorinda S Chung, Luke B. Evnin, Tracy Frech and 18 more

The Journal of Rheumatology, 52(3), 263–269 · Published 15 January 2025 · DOI 10.3899/jrheum.2024-0736

Open full textView at the publisherCite this paper

In brief

“Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis” is a 2025 journal article by Jeong Min Yu and 29 co-authors, published in The Journal of Rheumatology. OpenAlex counts 1 citations as of 22 November 2026. It is open access: the full text is free to read at PubMed Central.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
0.47
References
22
Authors
30

Abstract

Objective We aimed to evaluate the psychometric properties of the Scleroderma Skin Questionnaire (SSQ), a novel patient-reported outcome (PRO) to assess systemic sclerosis (SSc)–related skin symptoms. Methods Participants were recruited from the SSc Collaborative National Quality and Efficacy Registry (CONQUER). Internal consistency was determined using Cronbach α and McDonald ω total (ωt). The correlation of the SSQ was assessed with the modified Rodnan skin score (mRSS), physician global assessment (PGA), Scleroderma Health Assessment Questionnaire, 29-item Patient-Reported Outcomes Measurement Information System (PROMIS-29), and patient global assessment to assess criterion, convergent, and divergent validity. Correlations were also assessed between patients’ self-reported recall of skin changes over the past 6 months (“SSQ 6-Month”) and 6-month change in mRSS. Results The SSQ was administered to 799 adults (mean age 52.7; 83% female) enrolled in CONQUER. Cronbach α was 0.90 and ωtwas 0.92, indicating high internal consistency. The SSQ was moderately correlated with mRSS (r0.56), with stronger correlations in diffuse (r0.54) vs limited cutaneous subtypes (r0.24; allP< 0.05). The SSQ was also moderately-to-strongly correlated with PROMIS-29 physical function (r−0.50) and pain interference subscales (r0.61), strongly with Health Assessment Questionnaire score (r0.63) and severity subscale (r0.62), and moderately with PGA SSc activity score (r0.48; allP< 0.05). SSQ 6-Month correlated weakly with the 6-month change in mRSS (r0.26;P< 0.05). Conclusion SSQ demonstrated high reliability and moderate correlation with mRSS and legacy PROs. This study provides initial support for SSQ, but not SSQ 6-Month, to assess skin symptoms in patients with SSc.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Yu, J. M., VanBuren, J. M., Child, A., Alvey, J. S., Mandl, L. A., Pinheiro, L. C., Assassi, S., Bernstein, E. J., Castelino, F. V., Chung, L. S., Evnin, L. B., Frech, T., Hant, F. N., Hummers, L. K., Khanna, D., Lakin, K. S., Lebiedz‐Odrobina, D., Luo, Y., Makol, A., . . . Gordon, J. (2025). Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis. The Journal of Rheumatology, 52(3), 263–269. https://doi.org/10.3899/jrheum.2024-0736

MLA 9

Yu, Jeong Min, et al. “Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis.” The Journal of Rheumatology, vol. 52, no. 3, 2025, pp. 263–269. https://doi.org/10.3899/jrheum.2024-0736.

Chicago

Yu, Jeong Min, John M. VanBuren, Angela Child, Jessica S. Alvey, Lisa A. Mandl, Laura C. Pinheiro, Shervin Assassi, et al. 2025. “Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis.” The Journal of Rheumatology 52 (3): 263–269. https://doi.org/10.3899/jrheum.2024-0736.

Harvard

Yu, J. M. et al. (2025) ‘Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis’, The Journal of Rheumatology, 52(3), pp. 263–269. doi:10.3899/jrheum.2024-0736.

IEEE

J. M. Yu et al., “Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis,” The Journal of Rheumatology, vol. 52, no. 3, pp. 263–269, 2025, doi: 10.3899/jrheum.2024-0736.

BibTeX

@article{yu2025psychometric,
  title     = {{Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis}},
  author    = {Yu, Jeong Min and VanBuren, John M. and Child, Angela and Alvey, Jessica S. and Mandl, Lisa A. and Pinheiro, Laura C. and Assassi, Shervin and Bernstein, Elana J. and Castelino, Flavia V. and Chung, Lorinda S and Evnin, Luke B. and Frech, Tracy and Hant, Faye N. and Hummers, Laura Kathleen and Khanna, Dinesh and Lakin, Kimberly Showalter and Lebiedz‐Odrobina, Dorota and Luo, Yiming and Makol, Ashima and Molitor, Jerry A. and Moore, Duncan F. and Richardson, Carrie and Sandorfi, Nora and Shah, Ami A. and Shah, Ankoor and Shanmugam, Victoria K. and Skaug, Brian A. and Steen, Virginia D. and Volkmann, Elizabeth R. and Gordon, Jessica},
  journal   = {The Journal of Rheumatology},
  year      = {2025},
  volume    = {52},
  number    = {3},
  pages     = {263--269},
  doi       = {10.3899/jrheum.2024-0736},
  url       = {https://doi.org/10.3899/jrheum.2024-0736}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases

  • systemic sclerosis
  • patient-reported outcomes
  • cutaneous manifestations
  • psychometric properties
  • internal consistency
  • modified Rodnan skin score
  • convergent validity
  • discriminant validity

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Yu, J. M., VanBuren, J. M., Child, A., Alvey, J. S., Mandl, L. A., Pinheiro, L. C., Assassi, S., Bernstein, E. J., Castelino, F. V., Chung, L. S., Evnin, L. B., Frech, T., Hant, F. N., Hummers, L. K., Khanna, D., Lakin, K. S., Lebiedz‐Odrobina, D., Luo, Y., Makol, A., . . . Gordon, J. (2025). Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis. The Journal of Rheumatology, 52(3), 263–269. https://doi.org/10.3899/jrheum.2024-0736

How many times has this paper been cited?

1 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at PubMed Central: sign in and open the full text from this page.

Who wrote this paper?

Jeong Min Yu, John M. VanBuren, Angela Child, Jessica S. Alvey, Lisa A. Mandl, Laura C. Pinheiro, Shervin Assassi, Elana J. Bernstein, Flavia V. Castelino, Lorinda S Chung, Luke B. Evnin, Tracy Frech and 18 more.

What is the DOI of this paper?

10.3899/jrheum.2024-0736, permanently at https://doi.org/10.3899/jrheum.2024-0736. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.